ITRM930840A0 - Composizione teapeutica a base di interferone umano, impiego di interferone umano in tale composizione e relativo metodo. - Google Patents
Composizione teapeutica a base di interferone umano, impiego di interferone umano in tale composizione e relativo metodo.Info
- Publication number
- ITRM930840A0 ITRM930840A0 ITRM930840A ITRM930840A ITRM930840A0 IT RM930840 A0 ITRM930840 A0 IT RM930840A0 IT RM930840 A ITRM930840 A IT RM930840A IT RM930840 A ITRM930840 A IT RM930840A IT RM930840 A0 ITRM930840 A0 IT RM930840A0
- Authority
- IT
- Italy
- Prior art keywords
- human interferon
- composition
- theapeutic
- related method
- composition based
- Prior art date
Links
- 102000014150 Interferons Human genes 0.000 title 2
- 108010050904 Interferons Proteins 0.000 title 2
- 229940079322 interferon Drugs 0.000 title 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3476—Powered trocars, e.g. electrosurgical cutting, lasers, powered knives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3494—Trocars; Puncturing needles with safety means for protection against accidental cutting or pricking, e.g. limiting insertion depth, pressure sensors
- A61B17/3496—Protecting sleeves or inner probes; Retractable tips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1487—Trocar-like, i.e. devices producing an enlarged transcutaneous opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/320725—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with radially expandable cutting or abrading elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/32075—Pullback cutting; combined forward and pullback cutting, e.g. with cutters at both sides of the plaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3209—Incision instruments
- A61B17/3211—Surgical scalpels, knives; Accessories therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3474—Insufflating needles, e.g. Veress needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00184—Moving parts
- A61B2018/0019—Moving parts vibrating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M13/00—Insufflators for therapeutic or disinfectant purposes, i.e. devices for blowing a gas, powder or vapour into the body
- A61M13/003—Blowing gases other than for carrying powders, e.g. for inflating, dilating or rinsing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Plasma & Fusion (AREA)
- Otolaryngology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929226729A GB9226729D0 (en) | 1992-12-22 | 1992-12-22 | Therapeutic combination |
Publications (3)
Publication Number | Publication Date |
---|---|
ITRM930840A0 true ITRM930840A0 (it) | 1993-12-21 |
ITRM930840A1 ITRM930840A1 (it) | 1995-06-21 |
IT1261949B IT1261949B (it) | 1996-06-04 |
Family
ID=10727038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITRM930840A IT1261949B (it) | 1992-12-22 | 1993-12-21 | Composizione terapeutica a base di interferone umano, impiego di interferone umano in tale composizione e relativo metodo. |
Country Status (24)
Country | Link |
---|---|
US (1) | US5830455A (it) |
EP (1) | EP0675730B1 (it) |
JP (2) | JP2849214B2 (it) |
KR (1) | KR100309059B1 (it) |
CN (1) | CN1094642A (it) |
AT (1) | ATE199643T1 (it) |
AU (1) | AU680858B2 (it) |
CA (1) | CA2152389A1 (it) |
DE (1) | DE69330032T2 (it) |
ES (1) | ES2156150T3 (it) |
FR (1) | FR2699407A1 (it) |
GB (1) | GB9226729D0 (it) |
HR (1) | HRP931510A2 (it) |
HU (1) | HUT72965A (it) |
IL (1) | IL108114A (it) |
IT (1) | IT1261949B (it) |
MY (1) | MY141415A (it) |
NO (1) | NO952469L (it) |
PL (1) | PL309398A1 (it) |
RU (1) | RU2145235C1 (it) |
TW (1) | TW286283B (it) |
WO (1) | WO1994014473A1 (it) |
YU (1) | YU79393A (it) |
ZA (1) | ZA939583B (it) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5508031A (en) * | 1986-11-21 | 1996-04-16 | Cetus Oncology Corporation | Method for treating biological damage using a free-radial scavenger and interleukin-2 |
DE4325547C2 (de) * | 1993-07-29 | 1997-11-27 | Max Planck Gesellschaft | Verwendung von Thiolverbindungen zur Therapie von Hepatitis-_Viren-induzierten Erkrankungen |
US6020205A (en) * | 1998-04-10 | 2000-02-01 | Immunosciences Lab, Inc. | Determination of intracellular antioxidant levels |
RU2156134C2 (ru) * | 1998-05-12 | 2000-09-20 | ООО "Формавит" | Биофармацевтический препарат на основе живой культуры bacillus и способ лечения заболевания инфекционной природы |
MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
NZ547204A (en) * | 2000-05-26 | 2008-01-31 | Idenix Cayman Ltd | Methods and compositions for treating flaviviruses and pestiviruses |
WO2002044717A1 (en) * | 2000-12-01 | 2002-06-06 | Cornell Research Foundation | Animal model for flaviviridae infection |
US6759061B2 (en) * | 2001-08-31 | 2004-07-06 | Renew Life, Inc. | Liver function improvement formulation |
JP2005504087A (ja) * | 2001-09-28 | 2005-02-10 | イデニクス(ケイマン)リミテツド | 4’が修飾されたヌクレオシドを使用するc型肝炎ウイルス治療のための方法および組成物 |
WO2003043573A2 (en) * | 2001-11-16 | 2003-05-30 | The Uab Research Foundation | Xanthine oxidase inhibition |
EP1536804A4 (en) | 2002-06-28 | 2007-10-31 | Idenix Cayman Ltd | 2'-C-METHYL-3'-O-L-VALINESTER-RIBOFURANOSYLCYTIDINE FOR THE TREATMENT OF FLAVIVIRIDAE INFECTIONS |
NZ537662A (en) | 2002-06-28 | 2007-10-26 | Idenix Cayman Ltd | 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
US7608600B2 (en) | 2002-06-28 | 2009-10-27 | Idenix Pharmaceuticals, Inc. | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
EP2799442A1 (en) | 2002-06-28 | 2014-11-05 | IDENIX Pharmaceuticals, Inc. | Modified 2' and 3' -nucleoside prodrugs for treating flaviridae infections |
JP2004155777A (ja) * | 2002-10-16 | 2004-06-03 | Asahi Kasei Pharma Kk | C型慢性肝炎治療剤 |
HUE033832T2 (en) | 2002-11-15 | 2018-01-29 | Idenix Pharmaceuticals Llc | 2'-methyl nucleosides in combination with interferon and Flaviviridae mutation |
WO2004050101A2 (en) * | 2002-11-29 | 2004-06-17 | Gpc Biotech Ag | Formulations useful against hepatitis c virus infections |
MXPA05006230A (es) | 2002-12-12 | 2005-09-20 | Idenix Cayman Ltd | Proceso para la produccion de nucleosidos ramificados-2'. |
WO2004084796A2 (en) * | 2003-03-28 | 2004-10-07 | Pharmasset Ltd. | Compounds for the treatment of flaviviridae infections |
ES2586668T3 (es) | 2003-05-30 | 2016-10-18 | Gilead Pharmasset Llc | Análogos de nucleósidos fluorados modificados |
CN1816538B (zh) * | 2003-07-22 | 2011-05-25 | 协和发酵生化株式会社 | 病毒感染症的预防或者治疗用组合物 |
AU2004258750A1 (en) * | 2003-07-25 | 2005-02-03 | Centre National De La Recherche Scientifique -Cnrs | Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis C |
WO2005018330A1 (en) * | 2003-08-18 | 2005-03-03 | Pharmasset, Inc. | Dosing regimen for flaviviridae therapy |
JP2005104852A (ja) * | 2003-09-29 | 2005-04-21 | Kyowa Hakko Kogyo Co Ltd | モービリウィルス感染症の予防または治療用組成物 |
WO2005107742A1 (en) | 2004-05-05 | 2005-11-17 | Yale University | Novel antiviral helioxanthin analogs |
CN101023094B (zh) | 2004-07-21 | 2011-05-18 | 法莫赛特股份有限公司 | 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备 |
MX2007003085A (es) | 2004-09-14 | 2007-08-02 | Pharmasset Inc | Preparacion de 2'-fluoro-2'-alquilo sustituido u otras ribofuranosil pirimidinas y purinas opcionalmente sustituidas y sus derivados. |
JP4516863B2 (ja) * | 2005-03-11 | 2010-08-04 | 株式会社ケンウッド | 音声合成装置、音声合成方法及びプログラム |
CU23432B6 (es) | 2005-11-02 | 2009-10-16 | Ct Ingenieria Genetica Biotech | Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras |
WO2007075876A2 (en) | 2005-12-23 | 2007-07-05 | Idenix Pharmaceuticals, Inc. | Process for preparing a synthetic intermediate for preparation of branched nucleosides |
US7964580B2 (en) | 2007-03-30 | 2011-06-21 | Pharmasset, Inc. | Nucleoside phosphoramidate prodrugs |
TW200946541A (en) * | 2008-03-27 | 2009-11-16 | Idenix Pharmaceuticals Inc | Solid forms of an anti-HIV phosphoindole compound |
US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
EP2376514A2 (en) | 2008-12-23 | 2011-10-19 | Pharmasset, Inc. | Nucleoside analogs |
NZ593647A (en) | 2008-12-23 | 2013-08-30 | Gilead Pharmasset Llc | Synthesis of purine nucleosides |
MX2011006891A (es) | 2008-12-23 | 2011-10-06 | Pharmasset Inc | Fosforamidatos de nucleosidos. |
TWI576352B (zh) | 2009-05-20 | 2017-04-01 | 基利法瑪席特有限責任公司 | 核苷磷醯胺 |
US8618076B2 (en) | 2009-05-20 | 2013-12-31 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
AU2011235112B2 (en) | 2010-03-31 | 2015-07-09 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
US8563530B2 (en) | 2010-03-31 | 2013-10-22 | Gilead Pharmassel LLC | Purine nucleoside phosphoramidate |
US10838095B2 (en) | 2010-08-05 | 2020-11-17 | Pgs Geophysical As | Wavefield deghosting of seismic data recorded using multiple seismic sources at different water depths |
AU2011336632B2 (en) | 2010-11-30 | 2015-09-03 | Gilead Pharmasset Llc | Compounds |
US8889159B2 (en) | 2011-11-29 | 2014-11-18 | Gilead Pharmasset Llc | Compositions and methods for treating hepatitis C virus |
US8809354B2 (en) | 2011-12-31 | 2014-08-19 | Sheikh Riazuddin | 3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections |
NZ716840A (en) | 2013-08-27 | 2017-06-30 | Gilead Pharmasset Llc | Combination formulation of two antiviral compounds |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1526205A (en) * | 1974-11-07 | 1978-09-27 | Searle & Co | Treatment of interferon-like material |
US4100150A (en) * | 1975-11-04 | 1978-07-11 | G. D. Searle & Co. | Stabilization of interferon against mechanical stress using thioctic acid |
US4762705A (en) * | 1981-11-10 | 1988-08-09 | Adolf W. Schwimmer | Cancer therapy with interferon |
US4927762A (en) * | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
CH666814A5 (it) * | 1986-07-24 | 1988-08-31 | Inpharzam Int Sa | Composizione farmaceutica idrosolubile contenente n-acetil-cisteina. |
US4985241A (en) * | 1986-11-21 | 1991-01-15 | Cetus Corporation | Therapeutic combination of free-radical scavenger and tumor necrosis factor |
CA1321349C (en) * | 1986-11-21 | 1993-08-17 | Robert Zimmerman | Therapeutic combination of free-radical scavenger or metabolic inhibitor and biologically active protein |
IT1231012B (it) * | 1989-07-27 | 1991-11-08 | Zambon Spa | Composizione farmaceutica per uso orale contenente nac. |
US5248697A (en) * | 1990-09-20 | 1993-09-28 | Brigham And Women's Hospital | Enhancement of glutathione levels with glutamine |
ES2082908T3 (es) * | 1990-11-19 | 1996-04-01 | Manz Galvano Technik Gmbh | Dispositivo de drenaje y llaves de paso para tambores de inmersion en el tratamiento por galvanizado y/o quimico de superficies exteriores de piezas en masa. |
-
1992
- 1992-12-22 GB GB929226729A patent/GB9226729D0/en active Pending
-
1993
- 1993-04-12 TW TW082102718A patent/TW286283B/zh active
- 1993-12-20 ES ES94902910T patent/ES2156150T3/es not_active Expired - Lifetime
- 1993-12-20 DE DE69330032T patent/DE69330032T2/de not_active Expired - Fee Related
- 1993-12-20 YU YU79393A patent/YU79393A/sh unknown
- 1993-12-20 WO PCT/GB1993/002600 patent/WO1994014473A1/en active IP Right Grant
- 1993-12-20 EP EP94902910A patent/EP0675730B1/en not_active Expired - Lifetime
- 1993-12-20 HU HU9501841A patent/HUT72965A/hu unknown
- 1993-12-20 KR KR1019950702659A patent/KR100309059B1/ko not_active IP Right Cessation
- 1993-12-20 PL PL93309398A patent/PL309398A1/xx unknown
- 1993-12-20 AU AU57076/94A patent/AU680858B2/en not_active Ceased
- 1993-12-20 RU RU95113492A patent/RU2145235C1/ru active
- 1993-12-20 AT AT94902910T patent/ATE199643T1/de not_active IP Right Cessation
- 1993-12-20 JP JP6514930A patent/JP2849214B2/ja not_active Expired - Lifetime
- 1993-12-20 CA CA002152389A patent/CA2152389A1/en not_active Abandoned
- 1993-12-21 IT ITRM930840A patent/IT1261949B/it active IP Right Grant
- 1993-12-21 MY MYPI93002794A patent/MY141415A/en unknown
- 1993-12-21 HR HR931510A patent/HRP931510A2/hr not_active Application Discontinuation
- 1993-12-21 IL IL10811493A patent/IL108114A/en active IP Right Grant
- 1993-12-21 CN CN93121281A patent/CN1094642A/zh active Pending
- 1993-12-21 FR FR9315349A patent/FR2699407A1/fr active Pending
- 1993-12-21 ZA ZA939583A patent/ZA939583B/xx unknown
- 1993-12-21 JP JP5322685A patent/JPH06234657A/ja active Pending
-
1995
- 1995-06-20 NO NO952469A patent/NO952469L/no not_active Application Discontinuation
-
1996
- 1996-09-06 US US08/706,645 patent/US5830455A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HU9501841D0 (en) | 1995-08-28 |
JPH06234657A (ja) | 1994-08-23 |
TW286283B (it) | 1996-09-21 |
ITRM930840A1 (it) | 1995-06-21 |
IL108114A (en) | 1999-12-31 |
US5830455A (en) | 1998-11-03 |
KR100309059B1 (ko) | 2002-06-20 |
AU5707694A (en) | 1994-07-19 |
NO952469D0 (no) | 1995-06-20 |
MY141415A (en) | 2010-04-30 |
YU79393A (sh) | 1996-10-09 |
EP0675730B1 (en) | 2001-03-14 |
GB9226729D0 (en) | 1993-02-17 |
RU2145235C1 (ru) | 2000-02-10 |
CA2152389A1 (en) | 1994-07-07 |
PL309398A1 (en) | 1995-10-02 |
ATE199643T1 (de) | 2001-03-15 |
DE69330032D1 (de) | 2001-04-19 |
JP2849214B2 (ja) | 1999-01-20 |
ES2156150T3 (es) | 2001-06-16 |
IL108114A0 (en) | 1994-04-12 |
NO952469L (no) | 1995-06-20 |
DE69330032T2 (de) | 2001-09-06 |
HUT72965A (en) | 1996-06-28 |
IT1261949B (it) | 1996-06-04 |
JPH08504799A (ja) | 1996-05-21 |
AU680858B2 (en) | 1997-08-14 |
CN1094642A (zh) | 1994-11-09 |
WO1994014473A1 (en) | 1994-07-07 |
EP0675730A1 (en) | 1995-10-11 |
FR2699407A1 (fr) | 1994-06-24 |
HRP931510A2 (en) | 1995-12-31 |
ZA939583B (en) | 1995-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITRM930840A0 (it) | Composizione teapeutica a base di interferone umano, impiego di interferone umano in tale composizione e relativo metodo. | |
FI894095A (fi) | Vaermare foer anvaendning i mikrovaogsugnar. | |
BR9202786A (pt) | Tampao,e tampao curvo | |
MX9203319A (es) | Metodo para la preparacion de cristales de alfa-2 interferona. | |
IT8821134A0 (it) | Frazioni oligomeriche procianidoliche, loro procedimentodi preparazione e composizioni farmaceutiche che le contengono. | |
MX14910A (es) | 2',3' -dideoxi-2',2'-difluoronucleosidos y procedimiento para su preparacion. | |
KR930702395A (ko) | 사이클로펩타이드, 이의 제조방법 및 약제로서의 이의 용도 | |
EE9600172A (et) | Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid | |
NL980042I1 (nl) | Plaatselijke formuleringen en transdermale afleversystemen die 1-isobutyl-1H-imidazoc4,5-c!chinolin-4-amine bevatten. | |
DE68921031T2 (de) | Amino oder Hydrazinoperoxide, Derivate und ihre Verwendungen. | |
KR900701751A (ko) | 치환 알릴아민 유도체, 그의 제조방법 및 그의 용도 | |
DE58907026D1 (de) | Alkoxymethyl- und Alkenyloxymethyl-cyclohexane. | |
DE59004277D1 (de) | Copolymerisat sowie dessen Verwendung. | |
BR8904606A (pt) | Composicao,produto endurecivel e aplicacao | |
FI894323A (fi) | Antimikrobiaalinen ainekoostumus, menetelmä ja käyttö | |
MX9203453A (es) | Derivados de 2- piperidinil pirimidina -4- carboxamida, su preparacion y su aplicacion en terapeutica. | |
NO942228D0 (no) | Ipsapiron-legemiddeltilberedning | |
IT1239745B (it) | Impiego di a-amminofluorochetoni per la preparazione di medicamenti ad attivita' cardiovascolare e antipertensiva. | |
ITTO930026A0 (it) | Metodo per la preparazione e la lavorazione di propellenti. | |
NO306672B1 (no) | N,N-dietyl-8,8-dipropyl-2-azaspiro[4,5]decan-2-propanamindimaleat, farmasöytisk blanding omfattende forbindelsen samt anvendelse derav | |
KR930703291A (ko) | 치환된 피리딜피리미딘, 그의 제조방법 및 용도, 및 신규한 중간체 | |
DE196932T1 (de) | Nichtabsorbierbares arzneimittel in magensaftloeslicher und magensaftresistenter form. | |
IT1246344B (it) | Metodo di dosaggio enzimoimmunologio e corredo di dosaggio relativo. | |
IT230191Y1 (it) | Schienale di zaini e simili, perfezionato. | |
DE68902824D1 (de) | Senkrecht einstellbar rollender sessel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted |